Hyperstem Therapeutics

Hyperstem Therapeutics is a biotechnology company focused on leveraging its proprietary "Hyper-Stem" cell technology to advance regenerative medicine and oncology. The company's platform enables the creation of highly potent pluripotent stem cells that exhibit enhanced developmental potential and genomic stability compared to standard induced pluripotent stem cells. In addition to cell therapies, Hyperstem is developing small molecule drugs designed to target the "stemness" of cancer cells, aiming to eliminate the specific cell populations responsible for tumor recurrence and drug resistance. By addressing the root causes of cancer progression and tissue degeneration, the company seeks to provide next-generation therapeutic solutions for challenging diseases.